Dr. Reddy's Laboratories Ltd. announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent generic version of Remodulin® (treprostinil) Injection, approved by the FDA.
Dr. Reddy’s Treprostinil Injection is supplied as;
- 20 mg/20 mL
- 50 mg/20 mL
- 100 mg/20 mL or
- 200 mg/20 mL vials
For more information visit drreddys.com
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!